Molina Healthcare
MOH Large CapHealthcare · Healthcare Plans
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Molina Healthcare en bref
Molina Healthcare (MOH) is currently trading at 170,01 € with a market capitalization of 8,9 Md €. The trailing P/E ratio stands at 52.28x, with a forward P/E of 21.05x. The 52-week range spans from 105,54 € to 271,57 €; the current price is 37.4% below the yearly high. Year-over-year revenue growth stands at -4.3%. The net profit margin stands at 0.44%.
💰 Dividende
Molina Healthcare currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
16 analystes évaluent Molina Healthcare (MOH) au consensus : Conserver. L'objectif de cours moyen est de 165,85 €, soit un potentiel de -2.45% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 112,46 € à 228,40 €.
Molina Healthcare : la thèse d'investissement en détail
Molina Healthcare (MOH) operates in the Healthcare — specifically Healthcare Plans — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario baissier
Revenue is contracting at -4.3% year-over-year — until that trend reverses, valuation is exposed to further downgrades. With a net margin of just 0.44%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion.
Valorisation en contexte
The EV/EBITDA multiple of 8.06x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.
Signal Smart Money
On the institutional side, Molina Healthcare appears in the disclosed holdings of Burry. Smart-money managers track positioning, fundamentals and competitive dynamics with research budgets few retail investors can match — when several converge on the same name, it is rarely random. That doesn't mean blind copying makes sense, but it does raise the bar for the bear case.
À surveiller
- The forward P/E of 21.05x is meaningfully below the trailing 52.28x — analysts expect earnings to step up; the next earnings release is the test.
Thèse d'investissement : forces et faiblesses
- Free cash flow positif
- –CA en contraction (-4.3% sur un an)
- –Faible rentabilité (marge 0.44%)
- –Multiple de valorisation élevé (P/E 52.28x)
- –Actuellement jugée surévaluée
Aperçu technique
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profil de risque
The data points to relatively defensive market behavior, elevated short interest (5.66%).
Trading Data
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Molina Healthcare?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
